AstraZeneca U.S. Processing Facility

Albemarle County, Virginia

AstraZeneca is constructing a state-of-the-art pharmaceutical manufacturing complex at the Rivanna Futures Site in Albemarle County, Virginia. The project encompasses two major facilities: one for active pharmaceutical ingredient (API) production targeting chronic diseases, and another dedicated to antibody-drug conjugates for oncology therapies. With a total investment of $4.5 billion, this is the largest single manufacturing investment in AstraZeneca’s history, expected to create 600 direct jobs and 3,000 indirect jobs. The facility is currently under construction and will serve as a cornerstone for AstraZeneca’s U.S. expansion and innovation in life sciences.